▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3345 by analyst upside · 2026-09-28
INMD
InMode Ltd.
Healthcare · Market Cap $821M · P/E 11.8x
ANALYST PRICE TARGET
+13.4%
implied upside to consensus target
Current Price $14.26
Consensus Target $16.17
Bull Target $17.0
Bear Target $15.0
Analysts Covering 3
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
3
Sell
0
52-Week Low $12.72
52-Week High $16.74
YTD Return -3.6%
FUNDAMENTALS
Market Cap $821M
P/E Ratio (TTM) 11.8x
Forward P/E 10.4x
EPS (TTM) $1.21
PEG Ratio 0.83
Dividend Yield N/A
Revenue (TTM) $375M
Profit Margin 20.7%
52-WEEK RANGE
52-Week Low $12.72
52-Week High $16.74
Current Price $14.26
Bear Target $15.0
Bull Target $17.0
● Now $14.26 ● Target $16.17
TRADING DATA
Avg Volume 535K
YTD Return -3.6%
Analyst Count 3
Consensus Hold
Upside to Target +13.4%
Last Updated 2026-09-28

ANALYST SUMMARY

InMode Ltd. (INMD) is currently trading at $14.26 with a Wall Street consensus price target of $16.17, implying potential upside of 13.4% over the next 12 months. 3 analysts currently cover INMD, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $17.0, while the most cautious has a target of $15.0.

INMD operates in the Healthcare sector with a market capitalisation of $821M. The stock is down 3.6% year-to-date and is currently trading near the lower end of its 52-week range of $12.72 – $16.74.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

BVS +27.4%
Bioventus Inc.
$943M · P/E 17.7x · Buy
AMN +4.6%
AMN Healthcare Services, Inc.
$1B · P/E 12.8x · Buy
OMER +37.0%
Omeros Corporation
$1B · P/E 12.2x · Buy
KMDA +54.8%
Kamada Ltd.
$503M · P/E 22.9x · Buy
HCSG +28.3%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for INMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-07 Building track record
Baird - Reiterated
Neutral → Neutral 2026-05-07 Building track record
Canaccord Genuity - Reiterated
Hold → Hold 2025-12-17 Building track record
UBS - Reiterated
Neutral → Neutral 2025-11-06 33% win rate (6 calls)
Canaccord Genuity - Reiterated
Hold → Hold 2025-10-10 Building track record
Needham reit
Hold → Hold 2025-10-10 20% win rate (5 calls)
Needham reit
Hold → Hold 2025-07-30 20% win rate (5 calls)
Barclays - Reiterated
Overweight → Overweight 2025-07-30 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
11/30
Consensus clarity
27/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →